Form 4: Royalty Pharma CFO Receives Stock Grant
Insider Transaction (Form 4)
Terrance P. Coyne, EVP & CFO of Royalty Pharma plc, reported multiple transactions in common stock on August 5, 2026.
Summary
- Grant/award: acquired 11,002 Class A Ordinary Shares on August 5, 2026; holds 11,002 after (Indirect).
- Bona fide gift: disposed of 18,500 Class E Ordinary Shares on August 7, 2026; holds 1,788,777 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Terrance P. Coyne — Officer (EVP & CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Grant/award | Class A Ordinary Shares | 11,002 | — | — | 11,002 |
| 2026-08-07 | Bona fide gift | Class E Ordinary Shares | 18,500 | — | — | 1,788,777 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Grant/award (11,002 shares) |
| 2026-08-07 | Bona fide gift (18,500 shares) |
Keywords
insider transaction, Form 4, RPRX, Royalty Pharma plc, neutral, Terrance P. Coyne
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.